FCH
ARCT icon

Freestone Capital Holdings’s Arcturus Therapeutics ARCT Stock Holding History

Freestone Capital Holdings’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$144K Hold
18,655
– – ﹤0.01% 526
2025
Q4 		$114K Hold
18,655
– – ﹤0.01% 533
2025
Q3 		$344K Hold
18,655
– – 0.01% 404
2025
Q2 		$243K Hold
18,655
– – 0.01% 397
2025
Q1 		$198K Hold
18,655
– – 0.01% 425
2024
Q4 		$317K Hold
18,655
– – 0.01% 345
2024
Q3 		$433K Buy
18,655
+200
+1% +$4.28K 0.01% 312
2024
Q2 		$449K Buy
+18,455
New +$560K 0.02% 314

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return